Literature DB >> 14988581

Hemostatic factors as risk markers for intracerebral hemorrhage: a prospective incident case-referent study.

Lars Johansson1, Jan-Håkan Jansson, Birgitta Stegmayr, Torbjörn K Nilsson, Göran Hallmans, Kurt Boman.   

Abstract

BACKGROUND AND
PURPOSE: Abnormalities in the hemostatic system may cause hemorrhagic complications. The aim of the present study was to examine whether total concentrations of tissue plasminogen activator (tPA), plasminogen inhibitor-1 (PAI-1), tPA/PAI-1 complex, von Willebrand factor (VWF), and soluble thrombomodulin were associated with a first-ever intracerebral hemorrhage (ICH).
METHODS: This prospective study was an incident case-referent study nested within the Västerbotten Intervention Program and the Northern Sweden Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) cohorts. By 2000, approximately 74 000 subjects had been screened, and 39 ICH cases were defined according to the World Health Organization MONICA criteria. A total of 78 matched controls were selected from the same cohort.
RESULTS: The average time from screening to the ICH event was 5.1 years. tPA/PAI-1 complex, systolic and diastolic blood pressures, and hypertension were associated with ICH in the univariate analysis. In the multivariate model, only hypertension (odds ratio [OR], 3.96; 95% confidence interval [CI], 1.27 to 12.36) and the tertile with the highest level of VWF compared with the lowest tertile (OR, 0.27; 95% CI, 0.08 to 0.90) were independently associated with ICH. The OR for the combined exposure to hypertension and low levels of VWF was 8.95, indicating a possible synergistic interaction. No associations were observed for smoking, cholesterol, body mass index, PAI-1, tPA, and soluble thrombomodulin.
CONCLUSIONS: This study showed that hypertension and low concentrations of VWF were independently associated with ICH. Furthermore, we observed a possible synergistic interaction between low levels of VWF and hypertension, suggesting 2 different pathways in the development of ICH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988581     DOI: 10.1161/01.STR.0000119382.25543.2A

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  4 in total

1.  Hemostatic Markers and Long-Term Risk of Intracerebral Hemorrhage in Postmenopausal Women.

Authors:  Ju-Mi Lee; Juned Siddique; Hyeon Chang Kim; David Green; Linda Van Horn; Matthew Allison; Sylvia Wassertheil-Smoller; Philip Greenland
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-04-07       Impact factor: 2.136

2.  Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort.

Authors:  Jared D Sturgeon; Aaron R Folsom; W T Longstreth; Eyal Shahar; Wayne D Rosamond; Mary Cushman
Journal:  Stroke       Date:  2008-06-05       Impact factor: 7.914

Review 3.  Genetics of Spontaneous Intracerebral Hemorrhage: Risk and Outcome.

Authors:  Hongxiu Guo; Mingfeng You; Jiehong Wu; Anqi Chen; Yan Wan; Xinmei Gu; Senwei Tan; Yating Xu; Quanwei He; Bo Hu
Journal:  Front Neurosci       Date:  2022-04-11       Impact factor: 4.677

4.  Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study.

Authors:  Kristina Johansson; Jan-Håkan Jansson; Lars Johansson; Ingemar Bylesjö; Torbjörn K Nilsson; Mats Eliasson; Stefan Söderberg; Marcus Lind
Journal:  Cerebrovasc Dis Extra       Date:  2017-04-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.